159 related articles for article (PubMed ID: 1171241)
21. 2-Adamantyl- and 2-adamantylidene-2-ethylamines.
Mariani E; Schenone P
Farmaco Sci; 1976 Apr; 31(4):272-6. PubMed ID: 939326
[TBL] [Abstract][Full Text] [Related]
22. Adamantylthiourea derivatives as antiviral agents.
Tilley JW; Levitan P; Kramer MJ
J Med Chem; 1979 Aug; 22(8):1009-10. PubMed ID: 490532
[TBL] [Abstract][Full Text] [Related]
23. Rimantadine inhibits reproduction of influenza virus A/USSR/77.
Galegov GA; Pushkarskaya NL; Smirnova NR; Lvov ND; Yatsina AA; Zhdanov VM
Lancet; 1979 Feb; 1(8110):269-70. PubMed ID: 84920
[No Abstract] [Full Text] [Related]
24. Combined action of ribovirin and rimantadine in experimental myxovirus infection.
Galegov GA; Pushkarskaya NL; Obrosova-Serova NP; Zhdanov VM
Experientia; 1977 Jul; 33(7):905-6. PubMed ID: 891769
[No Abstract] [Full Text] [Related]
25. Inhibitory activity of the new adamantane derivative N,N'-bis(ethylene)-P(1-adamantyl)-phosphonic diamide against Rous sarcoma virus.
McGraw TL; Cates LA; Daley LS; Chen YC
Antiviral Res; 1981 Nov; 1(4):269-72. PubMed ID: 6280610
[TBL] [Abstract][Full Text] [Related]
26. Adamantane and protoadamantanealkanamines as potential anti-Parkinson agents.
Chakrabarti JK; Hotten TM; Sutton S; Tupper DE
J Med Chem; 1976 Jul; 19(7):967-9. PubMed ID: 940116
[TBL] [Abstract][Full Text] [Related]
27. Amino acid derivatives of adamantane carbocycle are capable of inhibiting replication of highly virulent avian influenza A/H5N1 virus.
Deryabin PG; Garaev TM; Finogenova MP; Botikov AG; Shibnev VA
Bull Exp Biol Med; 2014 May; 157(1):62-5. PubMed ID: 24909717
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of 1,2-dioleoyl-3-(alpha-14C-1-adamantoyl)-sn-glycerol and 1-14C-adamantanecarboxylic acid.
Villani AJ; Pfeiffer FR
J Pharm Sci; 1976 Aug; 65(8):1243-5. PubMed ID: 978446
[TBL] [Abstract][Full Text] [Related]
29. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
[TBL] [Abstract][Full Text] [Related]
30. [Search for anticholinergic agents. III. Synthesis of various adamantane derivatives].
Woliński J; Kordonowska B; Plachta D
Acta Pol Pharm; 1977; 34(1):17-22. PubMed ID: 848315
[No Abstract] [Full Text] [Related]
31. [Synthesis of derivatives of N-(1-adamantyl)-N'-urea with potential antiviral activity].
Skwarski D; Maliszewska H
Acta Pol Pharm; 1988; 45(5):391-4. PubMed ID: 3247849
[No Abstract] [Full Text] [Related]
32. Antiproliferative and antiviral activity of three libraries of adamantane derivatives.
Basarić N; Sohora M; Cindro N; Mlinarić-Majerski K; De Clercq E; Balzarini J
Arch Pharm (Weinheim); 2014 May; 347(5):334-40. PubMed ID: 24532384
[TBL] [Abstract][Full Text] [Related]
33. Phosphorus-nitrogen compounds. 21. Murine oncolytic and antifertility effect of adamantylaziridine compounds.
Cates LA; Cramer MB; Williams L
J Med Chem; 1978 Jan; 21(1):143-6. PubMed ID: 619145
[TBL] [Abstract][Full Text] [Related]
34. [Rimantadine as an inhibitor of influenza virus A/675/77 (H1N1) reproduction].
Galegov GA; Pushkarskaia NL; Smirnova NR; L'vov ND; Iatsyna AA
Vopr Virusol; 1979; (3):306-8. PubMed ID: 462929
[No Abstract] [Full Text] [Related]
35. [Effect of rimantadine on the synthesis of virus-specific RNA in the culture of cells infected with Sindbis virus].
Dikiĭ VV; Petkevich AS; Leont'eva NA; Galegov GA
Vopr Med Khim; 1976; 22(6):844-8. PubMed ID: 1027258
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antibacterial activity of adamantyl substituted pyrimidines.
Orzeszko B; Laudy AE; Starościak BJ; Orzeszko A; Kazimierczuk Z
Acta Pol Pharm; 2004; 61(6):455-60. PubMed ID: 15794338
[TBL] [Abstract][Full Text] [Related]
37. [Antiviral agents. 22. N-aliphatic, N-alicyclic and N-polycyclic substituted N'-(2-adamantyl)ureas and -thioureas].
Kreutzberger A; Tantawy A
Arzneimittelforschung; 1983; 33(4):512-4. PubMed ID: 6683528
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antiviral activity evaluation of some aminoadamantane derivatives.
Kolocouris N; Foscolos GB; Kolocouris A; Marakos P; Pouli N; Fytas G; Ikeda S; De Clercq E
J Med Chem; 1994 Sep; 37(18):2896-902. PubMed ID: 8071937
[TBL] [Abstract][Full Text] [Related]
39. Anti-influenza A activity of some N-substituted bicyclo[3.2.1]octane-3-spiro-3'-pyrrolidine hydrochlorides: synthesis and structure.
de la Cuesta E; Ballesteros P; Trigo GG
J Pharm Sci; 1984 Sep; 73(9):1307-9. PubMed ID: 6491959
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of novel purine-based coxsackievirus inhibitors bearing polycylic substituents at the N-9 position.
Dejmek M; Sála M; Plačková P; Hřebabecký H; Mascarell Borredà L; Neyts J; Dračínský M; Procházková E; Jansa P; Leyssen P; Mertlíková-Kaiserová H; Nencka R
Arch Pharm (Weinheim); 2014 Jul; 347(7):478-85. PubMed ID: 24652670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
